BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34277406)

  • 1. FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience.
    Di Carlo C; di Benedetto M; Vicenzi L; Costantini S; Cucciarelli F; Fenu F; Arena E; Mariucci C; Montisci M; Panni V; Patani F; Valenti M; Palucci A; Burroni L; Mantello G
    Front Oncol; 2021; 11():655322. PubMed ID: 34277406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
    Krengli M; Milia ME; Turri L; Mones E; Bassi MC; Cannillo B; Deantonio L; Sacchetti G; Brambilla M; Inglese E
    Radiat Oncol; 2010 Feb; 5():10. PubMed ID: 20137093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas.
    Nishioka T; Shiga T; Shirato H; Tsukamoto E; Tsuchiya K; Kato T; Ohmori K; Yamazaki A; Aoyama H; Hashimoto S; Chang TC; Miyasaka K
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1051-7. PubMed ID: 12095574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver variability in gross tumor volume contouring in non-spine bone metastases.
    de la Pinta C; LaTorre RG; Martínez-Lorca A; Fernández E; Hernanz R; Martín M; Domínguez JA; Muñóz T; Canales E; Vallejo C; Alarza M; Hervás A; Garví M; Pino V; Sancho S
    J Clin Transl Res; 2022 Dec; 8(6):465-469. PubMed ID: 36452000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
    Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of
    Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
    Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
    BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue.
    Samołyk-Kogaczewska N; Sierko E; Zuzda K; Gugnacki P; Szumowski P; Mojsak M; Burzyńska-Śliwowska J; Wojtukiewicz MZ; Szczecina K; Jurgilewicz DH
    Strahlenther Onkol; 2019 Sep; 195(9):780-791. PubMed ID: 31214735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of [(18)F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy.
    Lazzari R; Cecconi A; Jereczek-Fossa BA; Travaini LL; Dell' Acqua V; Cattani F; Rizzo S; Fodor C; Landoni F; Orecchia R
    Ecancermedicalscience; 2014; 8():405. PubMed ID: 24688597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
    Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
    Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
    Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-modality variation in gross tumor volume delineation in 18FDG-PET guided IMRT treatment planning for lung cancer.
    Song Y; Chan M; Burman C; Cann D
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3803-6. PubMed ID: 17946204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
    Frennered A; Scherman J; Buchwald P; Johnsson A; Sartor H; Zackrisson S; Trägårdh E; Nilsson MP
    BMC Cancer; 2021 Apr; 21(1):447. PubMed ID: 33888074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
    Newbold KL; Partridge M; Cook G; Sharma B; Rhys-Evans P; Harrington KJ; Nutting CM
    Acta Oncol; 2008; 47(7):1229-36. PubMed ID: 18661420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation.
    Garda AE; Navin PJ; Merrell KW; Martenson JA; Neben Wittich MA; Haddock MG; Sio TT; Rule WG; Ashman JB; Sheedy SP; Hallemeier CL
    Radiother Oncol; 2020 Aug; 149():128-133. PubMed ID: 32417349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.